FDA signs off on updated COVID-19 vaccines 

INDIANA – The FDA has signed off on updated COVID-19 vaccines that target circulating variants in the U.S. Drug manufacturers Moderna and Pfizer/BioNTech said.

Both vaccine manufacturers have said testing shows that their vaccines are effective against EG.5, the currently dominant strain in the United States.

The Advisory Committee on Immunization Practices, a group of independent experts that advises the US Centers for Disease Control and Prevention on its vaccination decisions is scheduled to meet today, Tuesday, to discuss COVID-19 vaccines.

After the CDC signs off on those recommendations, the vaccines can be administered. Health experts anticipate the vaccines could become available within just a few days at certain pharmacies and doctor’s offices, pending their expected approval.

Health officials are urging people to get vaccinated as soon as the shots are available amid the growing concerns about the effects that the triple threat of respiratory viruses – coronavirus, flu, and respiratory syncytial virus – this fall and winter season.

Get Vaccinated

To find COVID-19 vaccine locations near you:

Information: CNN